$SRPT Company News Small health companies see large

New Post Public Reply Private Reply Replies (0) Message Board

Sep 1, 2014 at 12:07 PM

$SRPT Company News

Small health companies see large gains on a big earnings day 5:34 p.m. July 30, 2014 - Russ Britt
Tiny biotechs Sarepta and Revance make big waves on a strong day for the sector 3:35 p.m. April 22, 2014 - Russ Britt
Stocks rise; S&P 500 in longest win streak in 6 mths 4:49 p.m. April 21, 2014 - Anora Mahmudova
Netflix recovers ahead of results; Newmont tops S&P 500 3:32 p.m. April 21, 2014 - Sue Chang
Biotech surges on hopes FDA will fast-track muscular dystrophy drug 12:54 p.m. April 21, 2014 - Russ Britt
U.S. stock futures flip-flop; Hasbro jumps 4% 9:05 a.m. April 21, 2014 - Barbara Kollmeyer
Sarepta to reapply for FDA approval of MD drug 8:34 a.m. April 21, 2014 - MarketWatch.com
Sarepta surges 74% on plans for drug application 7:40 a.m. April 21, 2014 - Saumya Vaishampayan
Sarepta up 75% on plans for drug application 7:33 a.m. April 21, 2014 - Saumya Vaishampayan
7 gut checks before the stock market's opening bell 8:54 a.m. July 25, 2013 - Shawn Langlois
7 gut checks before the stock market's opening bell 9:00 a.m. July 24, 2013 - Shawn Langlois
Sarepta up 21% on plans to submit drug application 7:55 a.m. July 24, 2013 - Sara Sjolin
Ignore your feelings, obey the market 1:15 p.m. July 23, 2013 - The Trading Deck
For stock speculators, it’s down to two choices 12:10 p.m. June 27, 2013 - The Trading Deck
5 stocks insiders are betting on 12:15 p.m. June 25, 2013 - Insider Monkey
How to get the Nasdaq out of neutral 3:11 p.m. June 18, 2013 - The Trading Deck
Tuesday’s movers: Apple snaps 3-day losing streak 5:09 p.m. April 16, 2013 - Sue Chang
The market that can do no wrong? 11:14 a.m. March 26, 2013 - The Trading Deck
6 stocks positioning for breakouts 9:53 a.m. March 15, 2013 - The Trading Deck
3 speculative names for a market stuck in neutral 9:49 a.m. March 14, 2013 - The Trading Deck

Ebola cases accelerating 7:10 a.m. Aug. 28, 2014 - Seeking Alpha
Tekmira Pharmaceuticals Corp. Is More Than Just A Short-Term Trade 3:12 p.m. Aug. 27, 2014 - Seeking Alpha
Sarepta partners with diagnostic firm to develop DMD tests 10:37 a.m. Aug. 21, 2014 - Seeking Alpha
Cash In on Taser's Gains With Moves in Options 10:35 a.m. Aug. 20, 2014 - Barrons.com
Sarepta Therapeutics Reports Wider Y/Y Loss, Revenues Miss - Analyst Blog 2:49 p.m. Aug. 12, 2014 - Zacks.com
Tekmira Ebola Drug Hold Lifted By FDA, Stock Soars 1:04 p.m. Aug. 8, 2014 - Investors Business Daily
Today's Market: News Moving These Names 11:09 a.m. Aug. 8, 2014 - Seeking Alpha
Today's Dead Cat Bounce Stock Is Sarepta Therapeutics (SRPT) 11:09 a.m. Aug. 8, 2014 - TheStreet.com
Sarepta's (SRPT) CEO Chris Garabedian on Q2 2014 Results - Earnings Call Transcript 5:45 p.m. Aug. 7, 2014 - Seeking Alpha
Sarepta Therapeutics (SRPT) Q2 2014 Results - Earnings Call Webcast 7:55 a.m. Aug. 7, 2014 - Seeking Alpha
10-Q: SAREPTA THERAPEUTICS, INC. 6:51 a.m. Aug. 7, 2014 - Edgar Online - (EDG = 10Q, 10K)
Sarepta Should Shut Up About Ebola, Focus on Job No. 1 12:07 p.m. Aug. 6, 2014 - TheStreet.com
'Fast Money' Recap: Geopolitical Pressures Weigh on Stocks 5:00 a.m. Aug. 6, 2014 - TheStreet.com
Sarepta Ready to Provide Ebola Drug if Needed 12:50 p.m. Aug. 5, 2014 - Barrons.com
PTC Therapeutics DMD drug gets conditional nod from European Commission 12:55 p.m. Aug. 4, 2014 - Seeking Alpha
Top Analyst Upgrades and Downgrades: Expedia, Hyatt, Ocwen, Strayer, SunPower, 3D Systems and More 8:05 a.m. Aug. 1, 2014 - 247WallSt.com
Sarepta Therapeutics Chairman Goolsbee Resigns 7:35 p.m. July 31, 2014 - The Wall Street Journal Interactive Edition
Sarepta Therapeutics (SRPT) Soars: Stock Rises 12.8% - Tale of the Tape 9:39 a.m. July 31, 2014 - Zacks.com
Sarepta up on FDA official's comments 11:50 a.m. July 30, 2014 - Seeking Alpha
Sarepta Up 12% As FDA Is 'Actively Engaged' On Drug Application 10:33 a.m. July 30, 2014 - benzinga.com

Sarepta Therapeutics to Present Company Overview at Upcoming Conferences 8:01 a.m. Aug. 28, 2014 - BusinessWire - BZX
Critical Alerts For Lowes, FuelCell Energy, Sarepta Therapeutics, Nuance Communications and Herbalife Released By InvestorsObserver 9:31 a.m. Aug. 20, 2014 - PR Newswire - PRF
Potential Payoffs Spur Big Board Biotech Action 3:04 p.m. Aug. 12, 2014 - ACCESSWIRE
Sarepta Therapeutics Announces Second Quarter 2014 Financial Results and Recent Corporate Developments 7:37 a.m. Aug. 7, 2014 - BusinessWire - BZX
Technical Data on Biotech Stocks -- Arrowhead Research, Celldex Therapeutics, Synthetic Biologics, StemCells, and Sarepta Therapeutics 8:50 a.m. Aug. 4, 2014 - PR Newswire - PRF
Sarepta Therapeutics Announces Appointment of John Hodgman As Interim Chairman 5:11 p.m. July 31, 2014 - BusinessWire - BZX
Sarepta Therapeutics to Present Company Overview at Canaccord Annual Growth Conference 11:15 a.m. July 31, 2014 - BusinessWire - BZX
Sarepta Therapeutics to Announce Second Quarter 2014 Financial Results and Corporate Update on August 7, 2014 10:54 a.m. July 31, 2014 - BusinessWire - BZX
Critical Alerts For Johnson Controls, Sarepta Therapeutics, China Life Insurance, Finisar, and Petroleo Brasileiro Released By InvestorsObserver 9:31 a.m. July 31, 2014 - PR Newswire - PRF
Flexion Therapeutics Announces Board Changes 8:01 a.m. July 24, 2014 - GlobeNewswire
Critical Alerts For General Electric, Sarepta Therapeutics, iRobot, Goldman Sachs, and Baidu Released By InvestorsObserver 9:31 a.m. July 16, 2014 - PR Newswire - PRF
Sarepta Therapeutics Reports Long-Term Outcomes Through 144 Weeks from Phase IIb Study of Eteplirsen in Duchenne Muscular Dystrophy 8:31 a.m. July 10, 2014 - BusinessWire - BZX
Stock Watchout on Biotech Industry -- Research on ARIAD Pharma, Geron, Seattle Genetics, and Sarepta Therapeutics 7:30 a.m. June 26, 2014 - PR Newswire - PRF
Critical Alerts For RF Micro Devices, Sarepta Therapeutics, Smith & Wesson, SINA, and Canadian Solar Released By InvestorsObserver 9:31 a.m. June 20, 2014 - PR Newswire - PRF
Sarepta Therapeutics to Present Company Overview at the JMP Securities Healthcare Conference on June 24 4:30 p.m. June 18, 2014 - BusinessWire - BZX
SHAREHOLDER ALERT: The Law Firm of Levi & Korsinsky, LLP Launches an Investigation into Sarepta Therapeutics Inc. Regarding Possible Breaches of Fiduciary Duty 12:59 p.m. June 9, 2014 - PR Newswire - PRF
Sarepta Therapeutics Opens New Global Headquarters in Cambridge, Mass. 9:42 a.m. June 2, 2014 - BusinessWire - BZX
Clinical Study Results, Schedule of Upcoming Conferences, Dividend Declaration, and Services Agreement - Analyst Notes on Gilead, Quest Diagnostics, Sarepta Therapeutics, Incyte and Centene 5:10 a.m. May 28, 2014 - PR Newswire - PRF
Critical Alerts For Celldex Therapeutics, Best Buy, Weibo, Sarepta Therapeutics, and Dollar Tree Released By InvestorsObserver 9:31 a.m. May 23, 2014 - PR Newswire - PRF
Top Gainers Technical Coverage -- Research on NeuStar, Signet Jewelers, Galena Biopharma, and Sarepta Therapeutics 9:29 a.m. May 23, 2014 - PR Newswire - PRF

Newer

Older

Scroll down for more posts ▼

Top 10 Most Recent News Articles

An Extra Helping of Community Spirit Rutter Mills is back on the scene again this Thanksgiving, slinging out a thousand turkeys to show their appreciation for the community they’ve called home since 1959. This initiative is the second iteration of their Turkey Drop, an event that's set to become a cherished tradition for years to come. Last year's event only teased the...

James Hardie Joins S&P MidCap 400; Roku Acquired

A Shift in the MidCap 400: What's Up? Well, wouldn’t you know it, James Hardie Industries is making waves as it steps into the S&P MidCap 400. This move happens because Fox Corp. has nabbed Roku in a deal worthy of some popcorn. Come November 11, when the trading floor wakes up, James Hardie will be in and Roku will be out. Pretty neat switcheroo if you ask me. Inside...

Off-Broadway Play 'DUST' Raises Autism Support Funds

Here's the scoop: an Off-Broadway production just did something many big hitters can't pull off. 'DUST,' a show crafted like a love letter to the American West, managed to rustle up $30,000 for young adults grappled with autism. Partnering with no less than Yale's Cultural Autism Studies and the Ed Asner Family Center, this effort hit the mark in more ways than one. An...

Aurora Innovation Faces Legal Heat Amid Delays

Production Snags at Aurora Innovation Ah, investing – not for the faint-hearted. One day you're riding high, the next you're scraping by, and Aurora Innovation's (NASDAQ:AUR) investors just hit a rough patch. The autonomous trucking darling announced unexpected delays in its delivery schedule, sending shockwaves through its stock price and shaking investor confidence....

Koppers Faces Investigation: Investors Cautious Amid Probe

Deep Dive: Koppers' Financial Turmoil When a company throws a financial party, you don't expect the hangover to come in the form of an investigation notice. That’s what’s brewing over at Koppers Holdings Inc., leading many seasoned investors to take a hard, scrutinizing look at the books. The latest buzz? An inquiry into whether the company gave its investors the full...

Evaluating GLP-1 Telehealth? Key Questions to Consider

Navigating the Landscape of GLP-1 Telehealth Providers In the sprawling jungle of telehealth options for GLP-1 care, it's easy to feel like you're drowning in sameness. Picture this: you land on a sleek page promising the moon and stars, but who knows what's behind the curtain? That's where seasoned advice comes in, like a compass in this murky digital forest. Meant, a...

Pinterest Faces Legal Probe: Investor Concerns Rise

Legal Storms Gather on Pinterest's Horizon I remember a time when Pinterest was the darling of Wall Street, but here we are, staring at an investigation that's got more layers than an onion. On November 6, 2026, news broke that Kahn Swick & Foti, LLC (KSF) is sniffing around Pinterest's officers and directors. This is no small fry since KSF is steered by none other than...

Tenax Sued: Investors Face Class Action Over TNX-103

What Tenax Investors Need to Know Alright, folks, time to pull up a chair and pay attention to what's brewing with Tenax Therapeutics—yeah, we're talking NASDAQ: TENX. The company's head is spinning as it's caught up in a securities class action lawsuit. What's the fuss? The fine print here accuses Tenax of misleading investors about the effectiveness of their product,...

Paris Baguette Pioneers Drive-Thru in Oklahoma

Tapping The Unseen Potential In Bakery Cafes Every so often a business move comes along that makes you sit up and say, "Why the hell haven't they done this before?" Paris Baguette has finally cracked that code, rolling out its first-ever drive-thru in Moore, Oklahoma. Now, imagine yourself zipping through for a croissant without leaving the comfort of your car seat. Makes...

Invasive Procedures Don't Extend Life in Stable Heart Disease

Challenging Longstanding Beliefs Today’s news from the heart research front might set a few cardiology heads spinning. We’ve got big-time findings out of the ISCHEMIA-EXTEND study, throwing more weight on the evidence pile that early invasive heart procedures for patients with stable coronary artery disease don’t actually extend your life. Managing care with a blend...